Sequential Gemcitabine/Docetaxel Promising in NMIBC After BCG Relapse
SAN DIEGO — The use of sequential intravesical gemcitabine and docetaxel appeared effective and well tolerated in patients with high-risk non-muscle invasive bladder cancer (NMIBC) following the failure of bacillus Calmette-Guérin (BCG) therapy, a retrospective study showed. At a median follow-up of 18 months, the 6-, 12-, and 24-month high-grade recurrence-free survival (RFS) rates among […]
Tecovirimat Safe in Monkeypox, but Efficacy Is Less Clear
Tecovirimat (Tpoxx) was well tolerated among patients with monkeypox virus infection, though its efficacy in monkeypox is currently unclear, CDC researchers said. Among over 300 patients taking tecovirimat under the FDA-regulated Expanded Access Investigational New Drug (EA-IND) protocol, 6.9% were hospitalized after symptom onset, with a median duration of hospitalization of 4 days, reported Farrell […]